Ingrid E. Fakkert

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition

Janet R. Vos, Ingrid E. Fakkert, Joanne A. de Hullu et al. · JNCI Journal of the National Cancer Institute · 2019 · 69 citations · Full text

Medicine, Genetics, Oncology +17

Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer

Ingrid E. Fakkert, Elske Marije Abma, Iris G. Westrik et al. · European Journal of Cancer · 2014 · 35 citations · Full text

Medicine, Gynecology, Surgery +16

Evaluation of yield and experiences of age‐related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome

Janet R. Vos, Ingrid E. Fakkert, Liesbeth Spruijt et al. · International Journal of Cancer · 2020 · 29 citations · Full text

Medicine, Genetics, Oncology +17

Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers

Ingrid E. Fakkert, Marian J.E. Mourits, Liesbeth Jansen et al. · Cancer Prevention Research · 2012 · 25 citations · Full text

Medicine, Gynecology, Oncology +15

Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer

Ingrid E. Fakkert, E. van der Veer, Elske Marije Abma et al. · PLoS ONE · 2017 · 13 citations · Full text

Medicine, Endocrinology, Gynecology +17